NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Kotak Mahindra Bank Sees Improved Quarter Despite Asset Quality Pressure

Kotak Mahindra Bank (KMB) has reported a better-than-expected quarter, driven by improved fees, operating expenses, and asset quality. The bank's core profit after tax (PAT) beat estimates by 8.8%, thanks to a strategic shift in its business model.

The bank's decision to increase its unsecured mix of assets has led to a slower growth pace, as management has indicated that secured growth will not be sacrificed. As a result, the reported net interest margin (NIM) is expected to remain flat in fiscal year 2027 (FY27E) compared to FY26 levels of 4.6%. However, fee growth is expected to pick up in FY27, which may result in an increase in operating expenses.

Key Statistics

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Financial MetricFY26EFY27EFY28E
Net Interest Margin (NIM)4.6%4.6%4.4%
Fee Growth6.5%10.0%12.0%

The bank's asset quality pressure is expected to have a negative impact on profit after tax (PAT) in FY27/28E. However, this will be more than offset by lower operating expenses. As a result, the multiple on the bank's core assets-based value (ABV) has been cut to 2.0x, with a roll-forward to FY28 core ABV, and the target price has been trimmed to INR 480 from INR 500. The research firm retains a 'BUY' rating for Kotak Mahindra Bank.

Investor Takeaway

Investors should consider buying Kotak Mahindra Bank with a target price of Rs 480.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.